Title Credit Activity type Target audience Start and expiration dates
Hot Topics in Dyslipidemia From the 2018 American College of Cardiology Scientific Sessions
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
Webcast 04/04/2018 to 04/03/2019
AHA 2017: Applying PCSK9 Inhibitors to Improve Outcomes and the Overall Quality of Life for Patients with Dyslipidemia
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Medical Meeting Report 12/20/2017 to 12/19/2018
Applying PCSK9 Inhibitors to Optimize Outcomes in Patients with Dyslipidemia
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
Webcast 12/19/2017 to 12/18/2018
An Update on Emerging S1P Therapeutics for the Management of Patients With Relapsing Multiple Sclerosis
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Webcast 12/12/2017 to 12/11/2018
Strength in Numbers: A Team-Based Approach to Managing Patients with Hyponatremia (Part 2)
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
Webcast 12/11/2017 to 12/10/2018
Strength in Numbers: A Team-Based Approach to Managing Patients with Hyponatremia (Part 1)
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
Webcast 12/11/2017 to 12/10/2018
The Role of PCSK9 Inhibitors in Lowering LDL-C and Reducing Cardiovascular Risk in Patients with Dyslipidemia
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Webcast 10/11/2017 to 10/10/2018
Optimizing Patient Outcomes in the Era of PCSK9 Inhibitor Therapeutics
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
Webcast 06/29/2017 to 06/28/2018
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of PCSK9 Inhibitor Therapeutics
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
Webcast 05/30/2017 to 05/29/2018